Home > Drug Search >
  • Targets: Picornain 3C protease
  •   > 
Drug Filter
Category:
chemistry (17) biology (1)
Status:
Approved (3) Withdrawn (1) Phase Ⅲ (2) Phase Ⅱ (8) Phase Ⅰ (4)
Clinical Stage:
Pending (2) Active (5) Discontinued (7)
Company:
Exelixis (1) Ferring Pharmaceuticals (1) GlaxoSmithKline (1) Leo Pharma (2) Lilly (1) Novartis (1) Onxeo (1) Onyx Pharmaceutical (2) Palatin Technologies (1) Pfizer (1) Roche (1) Teva (2) Karyopharm Therapeutics (1) Deciphera (1) Zelgen Biosciences (1) Ionis Pharmaceuticals (2) Baxter (1) Bayer (2) BioNumerik (1)
Indication:
Advanced renal cell carcinoma (RCC) (1) Appendicitis (1) BRAF mutant melanoma (1) Breast cancer (1) Chronic lymphocytic leukemia (CLL) (1) Colorectal neoplasms (1) Crohn's disease (1) Cutaneous T cell lymphoma (CTCL) (1) Diabetic macular edema (1) Differentiated thyroid cancer (2) Gastrointestinal stromal tumors (GISTs) (1) Hepatocellular carcinoma (HCC) (3) Lung cancer (1) Lymphoma (2) Melanoma (4) Metastatic colorectal cancer (CRC) (1) Multiple myeloma (MM) (1) Non small cell lung cancer (NSCLC) (1) Non-Hodgkin B-cell lymphomas (1) Ovarian cancer (1) Pancreatic cancer (1) Prostate cancer (1) Renal cell carcinoma (1) Small cell lung cancer (SCLC) (1) Solid tumours (6) Colorectal cancer (2) Unresectable hepatocellular carcinoma (1) Metastatic non-small cell lung cancer (1) Renal carcinoma (1) HRV infection (1)
Aprv. Year:
 (1) 2004 (1) 2012 (1) 2013 (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top